CN1898248A - 制备(3r,3a,6ar)-六氢呋喃并[2,3-b]呋喃-3-基(1s,2r)-3-[[(4-氨基苯基)磺酰基](异丁基)氨基]-1-苄基-2-羟基丙基氨基甲酸酯的方法 - Google Patents
制备(3r,3a,6ar)-六氢呋喃并[2,3-b]呋喃-3-基(1s,2r)-3-[[(4-氨基苯基)磺酰基](异丁基)氨基]-1-苄基-2-羟基丙基氨基甲酸酯的方法 Download PDFInfo
- Publication number
- CN1898248A CN1898248A CNA200480038298XA CN200480038298A CN1898248A CN 1898248 A CN1898248 A CN 1898248A CN A200480038298X A CNA200480038298X A CN A200480038298XA CN 200480038298 A CN200480038298 A CN 200480038298A CN 1898248 A CN1898248 A CN 1898248A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- amino
- solvent
- isobutyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (18)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03104949.7 | 2003-12-23 | ||
EP03104949 | 2003-12-23 | ||
US56818304P | 2004-05-04 | 2004-05-04 | |
US60/568,183 | 2004-05-04 | ||
PCT/EP2004/053692 WO2005063770A1 (en) | 2003-12-23 | 2004-12-23 | Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1898248A true CN1898248A (zh) | 2007-01-17 |
CN1898248B CN1898248B (zh) | 2011-08-17 |
Family
ID=34740665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200480038298XA Active CN1898248B (zh) | 2003-12-23 | 2004-12-23 | 制备(3r,3as,6ar)-六氢呋喃并[2,3-b]呋喃-3-基(1s,2r)-3-[[(4-氨基苯基)磺酰基](异丁基)氨基]-1-苄基-2-羟基丙基氨基甲酸酯的方法 |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1725566B1 (zh) |
KR (1) | KR101192859B1 (zh) |
CN (1) | CN1898248B (zh) |
AT (1) | ATE433982T1 (zh) |
AU (1) | AU2004309122B2 (zh) |
BR (1) | BRPI0417272B8 (zh) |
CA (1) | CA2549460C (zh) |
CY (1) | CY1109379T1 (zh) |
DE (1) | DE602004021640D1 (zh) |
DK (1) | DK1725566T3 (zh) |
ES (1) | ES2328701T3 (zh) |
HR (1) | HRP20090488T1 (zh) |
IL (1) | IL174960A (zh) |
MX (1) | MXPA06007211A (zh) |
NO (1) | NO337636B1 (zh) |
PL (1) | PL1725566T3 (zh) |
PT (1) | PT1725566E (zh) |
RU (1) | RU2376308C2 (zh) |
SI (1) | SI1725566T1 (zh) |
WO (1) | WO2005063770A1 (zh) |
ZA (1) | ZA200605163B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102584844A (zh) * | 2011-01-11 | 2012-07-18 | 浙江九洲药业股份有限公司 | 一种达芦那韦晶型及其制备方法 |
WO2014016660A3 (en) * | 2012-07-24 | 2014-03-13 | Laurus Labs Private Limited | Process for preparation of darunavir |
CN103893178A (zh) * | 2014-03-19 | 2014-07-02 | 中山大学 | 苯-磺酰胺类化合物在制备抗hiv-1病毒药物中的应用 |
CN102131815B (zh) * | 2008-09-01 | 2014-10-15 | 泰博特克药品公司 | 用于制备(3r,3as,6ar)-六氢呋喃并[2,3-b]呋喃-3-基(1s,2r)-3-[[(4-氨基苯基)磺酰基](异丁基)氨基]-1-苯甲基-2-羟基丙基氨基甲酸酯之方法 |
CN113896658A (zh) * | 2021-09-24 | 2022-01-07 | 上药康丽(常州)药业有限公司 | 一种利用微通道反应器合成地瑞那韦中间体的方法 |
CN114685322A (zh) * | 2020-12-30 | 2022-07-01 | 上海飞腾医药科技有限公司 | 一种抗hiv类药物中间体晶体的生长方法和所得晶体及其应用 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR058238A1 (es) | 2005-11-28 | 2008-01-23 | Tibotec Pharm Ltd | Compuestos y derivados de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih |
RS51675B (en) | 2006-11-09 | 2011-10-31 | Tibotec Pharmaceuticals | METHODS FOR THE PREPARATION OF HEXAHIDROFURO [2,3-B] FURAN-3-OLA |
WO2008132154A1 (en) | 2007-04-27 | 2008-11-06 | Tibotec Pharmaceuticals Ltd. | Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives |
US8592487B2 (en) | 2007-10-26 | 2013-11-26 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
WO2009055006A1 (en) * | 2007-10-26 | 2009-04-30 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
CN102348706B (zh) * | 2009-05-13 | 2015-03-04 | 明治制果药业株式会社 | 生产啶南平衍生物的方法 |
PL2477992T3 (pl) | 2009-09-17 | 2017-07-31 | Mylan Laboratories Limited | Proces przygotowania Darunawiru i jego amorficznych postaci |
WO2011083287A2 (en) | 2010-01-05 | 2011-07-14 | Cipla Limited | Darunavir polymorph and process for preparation thereof |
WO2011092687A1 (en) | 2010-01-28 | 2011-08-04 | Mapi Pharma Hk Limited | Process for the preparation of darunavir and darunavir intermediates |
US20160075643A1 (en) * | 2014-09-16 | 2016-03-17 | Zcl Chemicals Limited | Novel process to prepare intermediates of hiv-protease inhibitors thereof |
US10633390B2 (en) * | 2015-06-25 | 2020-04-28 | Msn Laboratories Private Limited | Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form |
EP3532478B1 (en) | 2016-10-27 | 2021-05-26 | Gilead Sciences, Inc. | Crystalline form of darunavir free base |
SI3541819T1 (sl) * | 2016-11-17 | 2021-02-26 | Janssen Sciences Ireland Unlimited Company | Poenostavljen postopek za pripravo darunavira |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4014220B2 (ja) | 1995-01-20 | 2007-11-28 | ジー.ディー.サール アンド カンパニー | ビス−スルホンアミドヒドロキシエチルアミノ レトロ ウイルスプロテアーゼインヒビター |
JP3665343B2 (ja) | 1995-02-03 | 2005-06-29 | 株式会社カネカ | α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法 |
US5756533A (en) | 1995-03-10 | 1998-05-26 | G.D. Searle & Co. | Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
JP4124818B2 (ja) | 1995-03-10 | 2008-07-23 | ジー.ディー.サール アンド カンパニー | ヘテロシクロカルボニルアミノ酸ヒドロキシエチルアミノスルホンアミドレトロウイルスプロテアーゼインヒビター |
US6150556A (en) | 1995-03-10 | 2000-11-21 | G. D. Dearle & Co. | Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
US5705500A (en) | 1995-03-10 | 1998-01-06 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
ES2267494T3 (es) | 1999-01-29 | 2007-03-16 | Kaneka Corporation | Procedimiento para la preparacion de derivados de treo-1,2-epoxi-3-amino-4-fenilbutano. |
KR20020046948A (ko) | 2000-12-12 | 2002-06-21 | 에가시라 구니오 | 에폭사이드 결정의 제조방법 |
CA2444895C (en) | 2001-05-11 | 2011-02-15 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
AU2002362189A1 (en) * | 2001-12-28 | 2003-07-24 | Ajinomoto Co., Inc. | Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same |
-
2004
- 2004-12-23 CA CA2549460A patent/CA2549460C/en active Active
- 2004-12-23 DK DK04805020T patent/DK1725566T3/da active
- 2004-12-23 DE DE602004021640T patent/DE602004021640D1/de active Active
- 2004-12-23 KR KR1020067009136A patent/KR101192859B1/ko active IP Right Grant
- 2004-12-23 BR BRPI0417272A patent/BRPI0417272B8/pt active IP Right Grant
- 2004-12-23 MX MXPA06007211A patent/MXPA06007211A/es active IP Right Grant
- 2004-12-23 AU AU2004309122A patent/AU2004309122B2/en active Active
- 2004-12-23 AT AT04805020T patent/ATE433982T1/de active
- 2004-12-23 CN CN200480038298XA patent/CN1898248B/zh active Active
- 2004-12-23 SI SI200431224T patent/SI1725566T1/sl unknown
- 2004-12-23 ES ES04805020T patent/ES2328701T3/es active Active
- 2004-12-23 PT PT04805020T patent/PT1725566E/pt unknown
- 2004-12-23 PL PL04805020T patent/PL1725566T3/pl unknown
- 2004-12-23 RU RU2006126670/04A patent/RU2376308C2/ru active
- 2004-12-23 WO PCT/EP2004/053692 patent/WO2005063770A1/en active Application Filing
- 2004-12-23 EP EP04805020A patent/EP1725566B1/en active Active
-
2006
- 2006-04-11 IL IL174960A patent/IL174960A/en active IP Right Grant
- 2006-06-22 ZA ZA2006/05163A patent/ZA200605163B/en unknown
- 2006-07-21 NO NO20063401A patent/NO337636B1/no unknown
-
2009
- 2009-09-15 HR HR20090488T patent/HRP20090488T1/xx unknown
- 2009-09-17 CY CY20091100961T patent/CY1109379T1/el unknown
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI482775B (zh) * | 2008-09-01 | 2015-05-01 | Tibotec Pharm Ltd | 用於製備(3r,3as,6ar)-六氫呋喃并〔2,3-b〕呋喃-3-基(1s,2r)-3-〔〔(4-胺基苯基)磺醯基〕(異丁基)胺基〕-1-苯甲基-2-羥基丙基胺基甲酸酯之方法 |
CN102131815B (zh) * | 2008-09-01 | 2014-10-15 | 泰博特克药品公司 | 用于制备(3r,3as,6ar)-六氢呋喃并[2,3-b]呋喃-3-基(1s,2r)-3-[[(4-氨基苯基)磺酰基](异丁基)氨基]-1-苯甲基-2-羟基丙基氨基甲酸酯之方法 |
CN102584844A (zh) * | 2011-01-11 | 2012-07-18 | 浙江九洲药业股份有限公司 | 一种达芦那韦晶型及其制备方法 |
CN102584844B (zh) * | 2011-01-11 | 2016-04-13 | 浙江九洲药业股份有限公司 | 一种达芦那韦晶型及其制备方法 |
US10544157B2 (en) | 2012-07-24 | 2020-01-28 | Laurus Labs Limited | Process for preparation of Darunavir |
US9475821B2 (en) | 2012-07-24 | 2016-10-25 | Laurus Labs Private Limited | Process for preparation of Darunavir |
US10214538B2 (en) | 2012-07-24 | 2019-02-26 | Laurus Labs Ltd. | Process for preparation of Darunavir |
WO2014016660A3 (en) * | 2012-07-24 | 2014-03-13 | Laurus Labs Private Limited | Process for preparation of darunavir |
CN103893178A (zh) * | 2014-03-19 | 2014-07-02 | 中山大学 | 苯-磺酰胺类化合物在制备抗hiv-1病毒药物中的应用 |
CN103893178B (zh) * | 2014-03-19 | 2016-06-01 | 中山大学 | 苯-磺酰胺类化合物在制备抗hiv-1病毒药物中的应用 |
CN114685322A (zh) * | 2020-12-30 | 2022-07-01 | 上海飞腾医药科技有限公司 | 一种抗hiv类药物中间体晶体的生长方法和所得晶体及其应用 |
CN114685322B (zh) * | 2020-12-30 | 2023-08-25 | 上海飞腾医药科技有限公司 | 一种抗hiv类药物中间体晶体的生长方法和所得晶体及其应用 |
CN113896658A (zh) * | 2021-09-24 | 2022-01-07 | 上药康丽(常州)药业有限公司 | 一种利用微通道反应器合成地瑞那韦中间体的方法 |
Also Published As
Publication number | Publication date |
---|---|
IL174960A0 (en) | 2006-08-20 |
ATE433982T1 (de) | 2009-07-15 |
PL1725566T3 (pl) | 2009-11-30 |
IL174960A (en) | 2011-06-30 |
DE602004021640D1 (de) | 2009-07-30 |
AU2004309122A1 (en) | 2005-07-14 |
AU2004309122B2 (en) | 2011-07-21 |
NO337636B1 (no) | 2016-05-23 |
RU2376308C2 (ru) | 2009-12-20 |
ES2328701T3 (es) | 2009-11-17 |
KR101192859B1 (ko) | 2012-10-19 |
DK1725566T3 (da) | 2009-10-05 |
CA2549460C (en) | 2014-08-05 |
NO20063401L (no) | 2006-07-21 |
BRPI0417272B1 (pt) | 2020-08-18 |
ZA200605163B (en) | 2007-12-27 |
RU2006126670A (ru) | 2008-01-27 |
CN1898248B (zh) | 2011-08-17 |
KR20060123740A (ko) | 2006-12-04 |
WO2005063770A1 (en) | 2005-07-14 |
HRP20090488T1 (en) | 2009-10-31 |
MXPA06007211A (es) | 2006-08-18 |
BRPI0417272A (pt) | 2007-03-27 |
BRPI0417272B8 (pt) | 2021-05-25 |
CY1109379T1 (el) | 2014-07-02 |
SI1725566T1 (sl) | 2009-12-31 |
EP1725566B1 (en) | 2009-06-17 |
CA2549460A1 (en) | 2005-07-14 |
PT1725566E (pt) | 2009-09-16 |
EP1725566A1 (en) | 2006-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1898248A (zh) | 制备(3r,3a,6ar)-六氢呋喃并[2,3-b]呋喃-3-基(1s,2r)-3-[[(4-氨基苯基)磺酰基](异丁基)氨基]-1-苄基-2-羟基丙基氨基甲酸酯的方法 | |
JP4818124B2 (ja) | (3R,3aS,6aR)−ヘキサヒドロフロ〔2,3−b〕フラン−3−イル(1S,1R)−3−〔〔(4−アミノフェニル)スルホニル〕(イソブチル)アミノ〕−1−ベンジル−2−ヒドロキシプロピルカルバマートの製造方法 | |
JP6871856B2 (ja) | 7H−ピロロ[2,3−d]ピリミジン誘導体の製造方法及びその中間体 | |
NO342965B1 (no) | Antiviralt bisfuran-derivat som HIV-protease-inhibitorer og mellomprodukter derav | |
TWI482775B (zh) | 用於製備(3r,3as,6ar)-六氫呋喃并〔2,3-b〕呋喃-3-基(1s,2r)-3-〔〔(4-胺基苯基)磺醯基〕(異丁基)胺基〕-1-苯甲基-2-羥基丙基胺基甲酸酯之方法 | |
SG180022A1 (en) | Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof | |
CN1553915A (zh) | 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法 | |
EP2794575A1 (en) | Synthesis of triazolopyrimidine compounds | |
CN1173863A (zh) | 邻氨基甲酰基-(d)-苯基丙氨醇化合物及其制备方法 | |
CN1066728C (zh) | 生产环氧化物的方法 | |
US8076513B2 (en) | Methods for the preparation of N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives | |
JP2013010732A (ja) | プロリン化合物の製造方法 | |
JP2007521277A (ja) | 化合物の製造 | |
CN1198433A (zh) | 用氨基甲酸酯类制备氯酮胺类的方法 | |
CN1213034C (zh) | 硝基一磺基苯甲酰胺类化合物 | |
CN101208292A (zh) | 由异羟肟酸制备胺类的方法 | |
KR101177821B1 (ko) | 시타글립틴 중간체의 제조 방법 및 이에 사용되는 중간체 | |
JP2017516790A (ja) | Azd5363の製造方法およびそれに用いられる新規中間体 | |
CN115996730A (zh) | 用于合成阳离子脂质的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: IRELAND JANSSEN R + D COMPANY Free format text: FORMER OWNER: JANSSEN R + D IRELAND Effective date: 20150716 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: JANSSEN R + D IRELAND Free format text: FORMER NAME: TIBOTEC PHARM LTD. Owner name: TIBOTEC PHARM LTD. Free format text: FORMER NAME: TIBOTEC NV |
|
CP01 | Change in the name or title of a patent holder |
Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Address after: The Irish Village Patentee after: TIBOTEC PHARMACEUTICALS Address before: The Irish Village Patentee before: TIBOTEC PHARMACEUTICALS Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150716 Address after: The Irish Village Patentee after: JANSSEN R&D IRELAND Address before: The Irish Village Patentee before: JANSSEN R&D IRELAND |